Spinal fluid chemo cocktail targets tough brain cancer spread

NCT ID NCT06663306

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early study tests whether injecting two cancer drugs (pemetrexed and bevacizumab) directly into the spinal fluid is safe for people with a specific type of lung cancer that has spread to the lining of the brain. The trial will enroll 19 adults whose cancer has worsened despite standard treatment. The main goal is to check for side effects, but researchers will also track how long participants live.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
pemetrexed and bevacizumab
What this could lead to
If it works, this could point toward a new treatment option for lung cancer that has spread to the lining of the brain, a condition with very few options.
What could go wrong
This is a very early phase 1 trial with only 19 people, so it is primarily testing safety, not effectiveness. The drugs are given directly into the spinal fluid, which carries risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanghai Chest Hospital

    RECRUITING

    Shanghai, 200030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.